Bayer’s (India) reported revenue of Rs 9,825 crore in Q4. Overall revenue increased by 9% in 2022-23
Bayer India has announced its results for the financial year (FY) and fourth quarter ended March 31, 2023. Revenue for the 2022-23 financial year was Rs 51,397 crore (about 4.38 billion yuan) compared to Rs 473,444 crore last year, representing an overall revenue growth of 9%. Profit before special items and pre-tax was Rs 8863 crore compared to Rs 7883 crore last year, up 12%. Pre-tax profit (excluding exceptional items) rose 17% to 9.901 billion rupees from 8.468 billion rupees.
In the fourth quarter of FY2022-23, the company recorded revenue of Rs 9,825 crore compared to Rs 9,633 crore a year ago, an increase of 2%. Profit before special items and taxes for the quarter stood at Rs 1,921 crore compared with Rs 1,895 crore a year ago.
Commenting on the quarterly results, Simon Thorsten Wiebusch, Executive Director of Bayer Cropscience, said, "Our sales growth in the fourth quarter was driven by strong plant protection sales and solid performance in our corn seed business, while overcoming some of the supply constraints we faced during the quarter. The Company's channel inventory has maintained good levels, but we are witnessing a normalization of Roundup ™ prices and volumes."″
″Simon Britsch, Chief Financial Officer of Bayer Cropscience, commented on the results for the fiscal year: "Solid performance in our crop protection and corn seed product portfolios helped us achieve a 9% increase in operating income for the fiscal year. While operating expenses increased due to headwinds from inflationary pressures, we continued to invest in key initiatives to drive long-term growth. The company disposed of its environmental sciences business in the third quarter of FY2022-23, generating exceptional income of Rs 1038 crore, "it said.
2026-10-17
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
ACE will be held during 14-16,Oct.,2026. There are detailed information about ACE.
-
Renaissance BioScience Receives Genome BC Funding to Extend RNAi Biopesticide Platform to Target Soil-Dwelling Crop Pests
-
Bayer and Syngenta Score Consecutive Regulatory and Legal Wins in the U.S.
-
Bayer Wins Big on Roundup
-
Glyphosate Becomes a Trade Fight
-
Bayer’s Flubendiamide Business Acquired by Tagros, Bringing a New Operator to Markets in Over 25 Countries Worldwide
-
Crystal Crop Protection Acquires Ethoxysulfuron Assets from Bayer AG
-
The project with an investment of ¥105 million and an annual output of 4000 tons of Propargite is to be built
-
Brazil's Agriconnection uses a new model to import and direct sell pesticides, with revenue exceeding $340 million
-
The Indian biopesticide market will grow at a CAGR of 9.38%
Recommend Reading
-
Middle East Capital Moves In: SABIC Plans RMB 33 Billion Stake in Rongsheng Petrochemical
-
“A Single Tube of Adhesive—Enough to Shake the Global Chemical Chessboard?”: The Hidden Power Struggle Behind the FTC’s Block of Henkel’s Liquid Nails Deal
-
Covestro Unveils TPU Application Development Hub in Guangzhou, Strengthening Regional Innovation Network
-
Braskem Weighs Out-of-Court Restructuring as $10 Billion Debt Burden Deepens Petrochemical Crisis
-
Ancora Offers Up to $1.2 Billion for H.B. Fuller Building Adhesives Business
-
Premium Global Chemical Sourcing Requests (1-5 Nov 2025)
-
This week, the Chinese anhydrous hydrogen fluoride market remains stable (11.3-11.6)
-
Bullish Support, Hydrogen Peroxide Prices Oscillate and Rise in China
-
Insufficient Positive Factors, This Week's Cyclohexanone Market in Shandong Narrowly Decreased
-
Ethanol Market Prices Weakly Consolidating